FDA Issues New Health Advisory For Psoriasis Drug Raptiva

The Food and Drug Administration has just issued a health advisory in response to reports of deadly brain infections in people who use the psoriasis drug Raptiva. There have been  three confirmed cases and one possible case of progressive multifocal leukoencephalopathy (PML) in people taking Raptiva. Of those four people, three are now dead. All patients has been treated with Raptiva for at least three years.

Continue →